Teladoc CAO sells 274 shares for tax withholding

Q: What insider transactions did TDOC’s Chief Accounting Officer report on this Form 4?

The Chief Accounting Officer reported converting 833 restricted stock units and 39 performance stock units into TDOC common shares on September 1, 2026, and selling 274 common shares on September 2, 2026, to cover tax withholding from the vesting.

Q: How many Teladoc Health (TDOC) shares did the insider sell and at what price?

He sold 274 shares of TDOC common stock on September 2, 2026, at $6.301 per share. According to the company’s disclosure, the sale was made to satisfy the tax withholding obligation from vesting equity awards.

Q: Were the TDOC insider’s equity awards in this Form 4 RSUs or PSUs?

The filing covers both restricted stock units (RSUs) and performance stock units (PSUs). On September 1, 2026, 833 RSUs and 39 PSUs converted into TDOC common stock on a one-for-one basis.

Q: Was a Rule 10b5-1 trading plan used for the TDOC insider’s sale?

No. The Form 4 indicates no Rule 10b5-1 trading plan for these transactions; the document-level 10b5-1 checkbox is not marked as an affirmed plan.

Q: What prior TDOC equity grants are referenced in this Form 4 footnotes?

Footnotes state a grant of 10,000 restricted stock units on March 1, 2025, vesting one-third on March 1, 2026, and 465 performance stock units earned on March 1, 2026, also vesting one-third on that date, with the remainder vesting in eight substantially equal quarterly installments.

Teladoc Health’s chief accounting officer converted RSUs and PSUs into shares and sold a portion solely to satisfy tax withholding from the vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) reports that Chief Accounting Officer Joseph Ronald Catapano settled equity awards and a related tax sale. On September 1, 2026, he converted 833 restricted stock units and 39 performance stock units into the same number of TDOC common shares on a one-for-one basis. On September 2, 2026, he sold 274 common shares at $6.301 per share, with the company stating this sale was to cover the tax withholding obligation arising from the vesting of these awards. Following the September 1 transactions, 5,001 restricted stock units and 232 performance stock units remained outstanding. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Catapano Joseph Ronald

Role Chief Accounting Officer

Sold 274 shs ($2K)

Approx. gross sale proceeds $2K

Type	Security	Shares	Price	Value
Sale	Common Stock ^F3	274	$6.301	$2K
Exercise	Restricted Stock Units ^{F1, F4}	833	$0.00	$0.00
Exercise	Performance Stock Units ^{F2, F5}	39	$0.00	$0.00
Exercise	Common Stock ^F1	833	--	--
Exercise	Common Stock ^F2	39	--	--

Holdings After Transaction: Restricted Stock Units — 5,001 contracts (Direct); Performance Stock Units — 232 contracts (Direct); Common Stock — 12,865 shares (Direct)

Footnotes (5)

F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4. On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5. On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Shares sold: 274 shares Sale price per share: $6.301 per share RSUs converted: 833 shares +5 more

8 metrics

Shares sold 274 shares Common stock sale on September 2, 2026 to cover tax withholding

Sale price per share $6.301 per share Common stock sale of 274 shares on September 2, 2026

RSUs converted 833 shares Restricted stock units converting into TDOC common stock on September 1, 2026

PSUs converted 39 shares Performance stock units converting into TDOC common stock on September 1, 2026

RSUs remaining 5,001 units Restricted stock units outstanding after September 1, 2026 transaction

PSUs remaining 232 units Performance stock units outstanding after September 1, 2026 transaction

RSUs granted March 1, 2025 10,000 units Restricted stock unit grant vesting over March 1, 2026 and eight quarterly installments

PSUs earned March 1, 2026 465 units Performance stock units earned with similar one-third and quarterly vesting schedule

Key Terms

restricted stock units, performance stock units, tax withholding obligation, vesting

4 terms

restricted stock units financial

"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance stock units financial

"Performance stock units convert to shares of TDOC common stock on a one-for-one basis"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation in respect of vesting"

vesting financial

"vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transactions did TDOC’s Chief Accounting Officer report on this Form 4?

The Chief Accounting Officer reported converting 833 restricted stock units and 39 performance stock units into TDOC common shares on September 1, 2026, and selling 274 common shares on September 2, 2026, to cover tax withholding from the vesting.

How many Teladoc Health (TDOC) shares did the insider sell and at what price?

He sold 274 shares of TDOC common stock on September 2, 2026, at $6.301 per share. According to the company’s disclosure, the sale was made to satisfy the tax withholding obligation from vesting equity awards.

Were the TDOC insider’s equity awards in this Form 4 RSUs or PSUs?

The filing covers both restricted stock units (RSUs) and performance stock units (PSUs). On September 1, 2026, 833 RSUs and 39 PSUs converted into TDOC common stock on a one-for-one basis.

How many RSUs and PSUs does the TDOC insider still hold after these transactions?

After the September 1, 2026 conversions, the reporting person held 5,001 restricted stock units and 232 performance stock units, as stated in the filing. These awards remain outstanding and continue to represent potential future TDOC share deliveries.

Was a Rule 10b5-1 trading plan used for the TDOC insider’s sale?

No. The Form 4 indicates no Rule 10b5-1 trading plan for these transactions; the document-level 10b5-1 checkbox is not marked as an affirmed plan.

What prior TDOC equity grants are referenced in this Form 4 footnotes?

Footnotes state a grant of 10,000 restricted stock units on March 1, 2025, vesting one-third on March 1, 2026, and 465 performance stock units earned on March 1, 2026, also vesting one-third on that date, with the remainder vesting in eight substantially equal quarterly installments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 04:12 PM Accepted by SEC EDGAR 09/03/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Catapano Joseph Ronald

(Last)

(First)

(Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/01/2026		M		833	A	⁽¹⁾	13,100	D
Common Stock	09/01/2026		M		39	A	⁽²⁾	13,139	D
Common Stock	09/02/2026		S		274⁽³⁾	D	$6.301	12,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	09/01/2026		M			833	⁽⁴⁾	⁽⁴⁾	Common Stock	833	$0	5,001	D
Performance Stock Units	⁽²⁾	09/01/2026		M			39	⁽⁵⁾	⁽⁵⁾	Common Stock	39	$0	232	D

Explanation of Responses:

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

4. On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

5. On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR